GHRP-2 · Research brief

Tesamorelin Price Per Month: What Drives Research Cost

Real Peptides Research TeamEditorial

Updated September 9, 20269 min read

54 WORDS

Short answer

The cheapest vial on the market is almost never the cheapest peptide. Two labs can buy a nominal 10mg of tesamorelin at the same nominal price and walk away with different amounts of usable material, because the mass printed on a vial is gross weight, and gross weight includes bound water and counter-ion salt.

Key takeaways

There is no published tesamorelin price per month, because monthly cost is a function of vials consumed, per-vial price and material lost inside the reconstituted stability window.
Tesamorelin is a 44-residue GHRH analogue, and chain length is the single largest driver of synthesis and purification cost.
The mass on a vial label is gross lyophilised powder weight, which includes residual water and acetate or trifluoroacetate counter-ion, so net peptide content is always lower.
Lyophilised material stores long term at -20°C or below, while reconstituted solution moves to 2-8°C with a short working window that freeze-thaw cycling shortens further.
A certificate of analysis without a chromatogram, a test date and a matching lot number is decoration, not verification.
Research-grade tesamorelin is supplied strictly for laboratory research and is not an approved drug product for human or veterinary use.

We run small-batch synthesis and test every lot, so we watch that gap open up constantly. Building a tesamorelin price per month figure without reading a certificate of analysis first means budgeting on a label instead of on peptide.

What is the tesamorelin price per month for research use?

There is no fixed tesamorelin price per month. Monthly spend equals vials consumed per month times per-vial price, minus whatever material expires inside the reconstituted stability window. Research-grade tesamorelin ships as 5mg or 10mg lyophilised vials, typically priced from double to low-triple digit dollars each.

Most buyers arrive expecting a published monthly figure, the way a pharmacy quotes a prescription. That number doesn't exist, because tesamorelin supplied for laboratory work is a research chemical priced per vial, not a dispensed drug product with a monthly supply. What follows covers what actually drives per-vial cost, why the per-vial and per-month numbers diverge, and how to verify purity on a certificate of analysis before you compare quotes.

What actually sets the price of a single vial

Tesamorelin is trans-3-hexenoyl-GRF(1-44) amide, a synthetic analogue of growth hormone releasing hormone that the published literature describes as an agonist at the GHRH receptor on anterior pituitary somatotrophs. Forty-four amino acids is the first thing your invoice reflects. Solid-phase peptide synthesis builds a chain one residue at a time, and each added residue is another coupling and deprotection cycle carrying its own chance of a deletion or truncation impurity. A 44-mer costs far more per milligram to make and to purify than a five-residue fragment, because the crude product contains a thicker forest of closely related sequences that preparative HPLC has to separate out.

Four other drivers stack on top of chain length:

Purity specification. Pushing a lot from 97% to 99% area purity means discarding more of the crude peak. Yield falls, cost per milligram rises.
Analytical package. HPLC, mass spectrometry, water content by Karl Fischer titration and residual counter-ion testing each cost money per lot. Suppliers who skip them are cheaper for a reason.
Batch size. Small-batch synthesis costs more per milligram than a large campaign and buys lot-level traceability in exchange.
Logistics. Lyophilised material held in domestic cold storage and dispatched within 24 hours carries real warehousing cost that a drop-shipped overseas parcel avoids.

Our team has priced this out across many synthesis runs, and the pattern holds: quotes that look impossibly low are almost always missing two of those four line items.

Why the per-vial number and the monthly number diverge

Two effects separate the price you pay from the cost you incur.

The first is net peptide content. A vial labelled 10mg contains 10mg of lyophilised powder, and that powder includes residual water plus the acetate or trifluoroacetate counter-ion left over from purification. Actual peptide mass is lower, sometimes meaningfully so. A COA reporting peptide content by amino acid analysis or nitrogen determination tells you what you bought. One reporting only chromatographic purity tells you how clean the powder is, not how much peptide sits inside it. Different questions, constantly conflated.

The second is the stability window. Lyophilised tesamorelin holds up long term at -20°C or below. Once reconstituted it moves to 2-8°C with a short working window, and every freeze-thaw cycle, stopper puncture and warm interval chips away at intact peptide through hydrolysis and aggregation.

Here is the budgeting mistake we see most often, and it isn't overpaying per vial. It's buying the largest vial available because dollars per milligram looks better on a spreadsheet, then pouring away reconstituted solution that outlived its window. A lab consuming small volumes weekly can pay a lower price per milligram and a higher effective tesamorelin price per month at the same time. Match the vial format to your consumption rate rather than to the unit-price comparison.

One more thing worth separating. The short plasma half-life reported for tesamorelin in pharmacokinetic literature says nothing about how long the material survives in your fridge. Those are unrelated numbers.

Reading a certificate of analysis before you compare quotes

The certificate of analysis is the only part of a peptide purchase you can independently check, and plenty of the documents circulating in this market don't survive a careful read.

A usable COA shows:

A lot number matching the label on the vial in your hand.
The actual HPLC chromatogram, with method, column, gradient and detection wavelength, not a purity percentage typed onto letterhead.
Mass confirmation by ESI-MS or MALDI-TOF, with the observed mass compared against the expected molecular weight for the sequence.
Peptide content, water content and residual solvent or counter-ion figures.
A test date and the name of the laboratory that ran it.

Red flags are just as informative: undated certificates, absent lot numbers, the same chromatogram trace reappearing under several different product names, and purity claims with no stated method. None of this changes the tesamorelin price per month printed on your ledger, but it completely changes what you are paying for. We publish certificates by lot in our COA library so a buyer can match a document to a specific vial rather than to a marketing page.

The regulatory framing belongs in any honest sourcing conversation. Tesamorelin is supplied for in vitro and laboratory research only, never for human or veterinary consumption. An approved prescription tesamorelin product exists for a specific clinical indication under medical supervision, and research-grade material is not that product and carries no such approval. If your question is really about an animal, talk to your veterinarian rather than a peptide supplier. Everything here is educational information about laboratory sourcing and handling, not guidance for use in a person.

Tesamorelin price per month: comparing three sourcing tiers

Price gaps between suppliers usually trace back to documentation and logistics rather than to the peptide itself. This is how the three common tiers compare once you translate them into a real monthly research cost.

Sourcing tier	Price signal per vial	Documentation supplied	Effect on effective monthly cost	Professional assessment
Overseas bulk reseller, drop-shipped	Lowest headline price, often well below domestic quotes	Generic certificate, frequently undated, lot number not tied to the vial you receive	Looks cheapest until a lot fails identity testing or arrives warm and gets discarded, which resets the month	Only defensible if you have in-house analytics to verify every single lot. Most labs do not, which is how the saving evaporates.
Domestic supplier, in-house COA only	Mid-range, predictable, usually stocked	Purity percentage and mass on company letterhead, testing performed internally	Stable month to month, but a re-order can differ from the lot you validated, forcing repeat baseline work	Workable for exploratory screening. Weak for anything you intend to publish, replicate or defend.
Small-batch domestic supplier, per-lot COA and cold stock	Highest headline price per vial	Full chromatogram, mass confirmation, peptide and water content, dated and lot-matched	Highest per vial, frequently lowest per usable milligram, with no weeks lost to failed or degraded material	Best real value once wasted peptide and repeated experiments are counted. This is the tier we built our catalog around.

What If: Sourcing and Handling Scenarios

What if my vial arrived at ambient temperature after shipping?

Check the certificate of analysis for the stated storage condition, then log the excursion in your lot records before doing anything else. Lyophilised peptide is considerably more forgiving than solution and tolerates short ambient transit, which is why reputable suppliers ship the powder rather than pre-mixed vials. What matters is duration and peak temperature, neither of which you can reconstruct after the fact unless you record it on arrival. Repeated or prolonged warm exposure drives deamidation and aggregation that no visual inspection at the bench will reveal.

What if the COA lists 99% purity but shows no chromatogram?

Treat the number as unverified and ask the supplier for the raw trace, the method and the detection wavelength. A purity figure without a chromatogram cannot be audited, cannot be tied to a lot, and cannot distinguish a genuine single peak from a percentage someone typed into a template. Reputable suppliers hand over the trace without hesitation because the trace is the product. Hesitation is itself the answer.

What if a supplier quotes me a monthly price instead of a per-vial price?

Walk away from that quote. A supplier presenting a tesamorelin price per month rather than a price per vial is implicitly pricing a consumption schedule, and consumption schedules only exist for people, not for in vitro research. Research-use-only material is sold by mass and by lot, full stop. That pricing structure signals a vendor operating outside research-use-only boundaries, which usually correlates with the same casual attitude toward analytics and cold chain.

What if the lyophilised cake looks shrunken, cracked or smeared up the vial wall?

Document it photographically, quote the lot number and contact the supplier before reconstituting anything. A well-lyophilised peptide cake sits as a uniform plug or fine film. Collapse, browning or material streaked up the glass wall points to a lyophilisation cycle problem or a temperature excursion in transit. Appearance is a weak diagnostic on its own, so pair it with the COA and, if the work is critical, independent identity testing rather than assuming the vial is fine because the powder is present.

The blunt truth about cheap tesamorelin

Let's be direct about this: a 44-residue peptide cannot be synthesised, purified to 98% or better, characterised analytically, lyophilised and cold-stored for the prices some sites advertise. Something has been removed from that process, and it is almost always the analytics. Under-length sequences, heavy counter-ion load and partial degradation are all invisible without a chromatogram, and none of them announce themselves in the vial. A tesamorelin price per month that undercuts the market by a wide margin isn't a discount. It's a quiet transfer of testing risk onto your bench.

If you're mapping a wider growth-hormone-axis research program, the same sourcing logic carries across compounds, from GHRP-2 and MK 677 through to the rest of the Real Peptides catalog, each supplied with a lot-matched certificate and dispatched from domestic stock within 24 hours.

The tesamorelin price per month you end up living with gets decided before you ever place an order, in the specification you insist on and the paperwork you refuse to skip. Peptide sourcing punishes headline-price shopping quietly and expensively, because degraded material rarely fails in an obvious way. It just makes your data slightly wrong, in a direction you won't notice for months. Read the chromatogram, match the lot number, then argue about price.

References

Peer-reviewed sources on Tesamorelin indexed in PubMed, listed for research context. Real Peptides supplies Tesamorelin for laboratory research use only.

Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials. Obesity research & clinical practice, 2026. PMID 41545261. doi:10.1016/j.orcp.2026.01.002
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. Drugs, 2011. PMID 21668043. doi:10.2165/11202240-000000000-00000
Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity. The Journal of infectious diseases, 2025. PMID 39813152. doi:10.1093/infdis/jiaf012
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. AIDS (London, England), 2024. PMID 38905488. doi:10.1097/QAD.0000000000003965
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial. Journal of clinical and translational science, 2023. PMID 36845310. doi:10.1017/cts.2022.515
Tesamorelin improves fat quality independent of changes in fat quantity. AIDS (London, England), 2021. PMID 33756511. doi:10.1097/QAD.0000000000002897
Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. Scientific reports, 2021. PMID 34006921. doi:10.1038/s41598-021-89966-y
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI insight, 2020. PMID 32701508. doi:10.1172/jci.insight.140134

Questions

Multiply the number of vials your protocol consumes in a month by the per-vial price, then add the cost of any reconstituted material discarded once it passes its working window at 2-8°C. That waste figure is what most budgets miss entirely. Labs that model cost per usable milligram rather than cost per vial usually find a smaller vial format is cheaper in practice, even at a worse headline unit price.

Not always, but it almost always means less documentation. Analytical testing, small-batch synthesis and cold storage are the line items that get removed to reach an unusually low tesamorelin price per month, and each of those is invisible in the vial. The only way to separate a genuine efficiency from a missing test is to read the certificate of analysis and confirm it carries a chromatogram, a method, a test date and a matching lot number.

Pricing varies widely by supplier, purity specification and quantity, but per-vial prices across domestic research suppliers typically fall somewhere between double and low-triple digit dollars. The spread reflects analytics and logistics far more than the peptide itself. Always confirm what documentation is included in the price, because an untested vial and a fully characterised vial are not the same product at any price.

Research-grade tesamorelin is supplied to researchers, laboratories and institutions for in vitro and laboratory research use only. It is not sold for human or veterinary consumption and is not an approved drug product. Buyers are responsible for handling the material in line with their own institutional and jurisdictional requirements.

Lyophilised tesamorelin is stored at -20°C or below and kept protected from light and moisture, which is the condition under which it remains stable long term. Once reconstituted it moves to 2-8°C with a short working window, and repeated freeze-thaw cycling, stopper punctures and warm intervals accelerate hydrolysis and aggregation. Always follow the storage condition stated on the certificate of analysis for the specific lot.

An approved prescription tesamorelin product exists for a specific clinical indication and is manufactured, released and monitored as a finished drug product under regulatory oversight. Research-grade tesamorelin is a laboratory chemical characterised by purity and identity testing, supplied for in vitro and research work only, with no approval for use in people or animals. The active sequence may be the same molecule, but the regulatory status, release testing and intended use are entirely different.

Match the lot number on the certificate to the lot number physically printed on your vial, then check that the document includes the HPLC chromatogram with method and detection wavelength, mass confirmation by ESI-MS or MALDI-TOF against the expected molecular weight, water and counter-ion content, a test date and the testing laboratory's name. A certificate missing the chromatogram or the date cannot be audited. Our certificates are published by lot so a buyer can match the document to the specific vial received.

Tesamorelin is 44 amino acids long, and solid-phase peptide synthesis adds one residue at a time through repeated coupling and deprotection cycles. Every extra cycle adds reagent cost and creates another opportunity for deletion or truncation impurities, so the crude product is harder and more wasteful to purify. Short peptides of five or ten residues need far fewer cycles and yield a cleaner crude, which is why their price per milligram sits much lower.

Net peptide content is the proportion of the lyophilised powder that is actually peptide, as opposed to residual water and the acetate or trifluoroacetate counter-ion carried over from purification. It is typically determined by amino acid analysis or nitrogen determination. Chromatographic purity tells you how clean the peptide fraction is; net peptide content tells you how much peptide is in the vial. Both numbers matter when comparing quotes, and only one of them is usually advertised.

Orders placed against in-stock lyophilised material are picked, packed and dispatched from domestic cold storage within 24 hours in our operation. Domestic dispatch matters for more than convenience, because it shortens the ambient transit window and reduces the chance of a temperature excursion that no visual inspection at the bench would catch. Always inspect the parcel and log arrival condition against the lot record.

No. Research-grade tesamorelin is supplied strictly for in vitro and laboratory research and is not intended, labelled or characterised for human or veterinary consumption. Questions about an approved medication belong with a licensed physician, and questions about an animal belong with a veterinarian, not with a peptide supplier.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA